118 related articles for article (PubMed ID: 21907174)
1. Can we predict, prevent, and minimize defibrillator shocks? Lessons learned from "remote monitoring".
Kantharia BK
Heart Rhythm; 2012 Jan; 9(1):32-3. PubMed ID: 21907174
[No Abstract] [Full Text] [Related]
2. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
[TBL] [Abstract][Full Text] [Related]
3. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in patients with implantable defibrillators.
Sakhuja R; Shah AJ; Keebler M; Thakur RK
Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
[TBL] [Abstract][Full Text] [Related]
5. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
[TBL] [Abstract][Full Text] [Related]
6. The application of cardiac computed tomography to visualize the coronary vein anatomy for implantation of cardiac resynchronization therapy in a patient with a cardiac right-lateral displacement and rotation.
Elders J; Winkens MH; Zegers ES; Bouwels LH
Eur Heart J Cardiovasc Imaging; 2012 Feb; 13(2):200. PubMed ID: 22127627
[No Abstract] [Full Text] [Related]
7. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT.
Slyngstad T; Huth Ruwald AC; Kutyifa V; McNitt S; Polonsky B; Solomon SD; Foster E; Goldenberg I; Wang PJ; Klein H; Zareba W; Moss AJ
Heart Rhythm; 2014 Jun; 11(6):1001-7. PubMed ID: 24502968
[TBL] [Abstract][Full Text] [Related]
9. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Aktas MK; Goldenberg I; Moss AJ; Huang DT; Kutyifa V; Wang PJ; Brenyo A; McNitt S; Zareba W; Barsheshet A
Am J Cardiol; 2014 Dec; 114(12):1855-60. PubMed ID: 25438913
[TBL] [Abstract][Full Text] [Related]
10. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
13. Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes.
Gheini A; Pourya A; Pooria A
Cardiovasc Hematol Disord Drug Targets; 2020; 20(4):249-259. PubMed ID: 33001020
[TBL] [Abstract][Full Text] [Related]
14. Using left-ventricular-only pacing to eliminate T-wave oversensing in a biventricular implantable cardiac defibrillator.
Khoo C; Bennett M; Chakrabarti S; LeMaitre J; Tung SK
Can J Cardiol; 2013 Feb; 29(2):254.e5-7. PubMed ID: 22902157
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiogram-electrogram desynchronization while using radiofrequency wandless telemetry during implantation of an implantable cardioverter defibrillator.
Cano O; Osca J; Buendía F; Sancho-Tello MJ; Olagüe J; Salvador A
Europace; 2011 Feb; 13(2):291-2. PubMed ID: 20798116
[No Abstract] [Full Text] [Related]
16. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
Sengupta J; Abdelhadi R
Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
Nagra B; Awan MU; Miriyala V; Kantharia BK
Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
[No Abstract] [Full Text] [Related]
18. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
Barsheshet A; Wang PJ; Moss AJ; Solomon SD; Al-Ahmad A; McNitt S; Foster E; Huang DT; Klein HU; Zareba W; Eldar M; Goldenberg I
J Am Coll Cardiol; 2011 Jun; 57(24):2416-23. PubMed ID: 21658562
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator.
Haghjoo M; Hajahmadi M; Fazelifar AF; Sadr-Ameli MA
Europace; 2011 Apr; 13(4):509-13. PubMed ID: 21296776
[TBL] [Abstract][Full Text] [Related]
20. Development of atrial fibrillation in recipients of cardiac resynchronization therapy: the role of atrial reverse remodelling.
Santulli G; D'ascia SL; D'ascia C
Can J Cardiol; 2012; 28(2):245.e17; author reply 245.e17-8. PubMed ID: 22244772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
